Biocon Surges In Trade As HSBC Upgrades The Stock To A Buy | CNBC TV18

(1:23)

Biocon Surges More Than 3% In Trade After US FDA Clears Its Malaysia Insulin Facility | CNBC TV18

(1:25)

Sensex, Nifty Open In Green; Biocon Surges over 3%, Airtel Down 1%

(4:20)

Biocon Surges After The US FDA Issues A VAI Status To Its Biologics Unit In Bengaluru | CNBC TV18

(1:8)

Q2 Review: Biocon PAT Doubles, Revenue Surges | BQ Prime

(15:36)

Boost For Biocon. Biosimilar Trastuzumab Accepted By EMA

(1:27)

Expect a recovery in earnings later this quarter: Biocon

(3:18)

Gravitas: Biocon executives charged with bribing regulators

(5:29)

Biocon: Resilience in speed and scaling up capacity

(1:30)

FREE Webinar - Explore Biotech / Pharma Careers Opportunities with Industry Experts! Join LIVE

(1:4:17)

Bispecific Antibody Overview \u0026 Production with CrossMab Technology

(46:47)

Biocon Share Price Jumps 7% In Trade | The Company Aims To Bring 5 New Products To The U.S.

(21:29)

Kiran Mazumdar-Shaw In Conversation with Sadhguru, 2017

(1:33:8)

FREE Webinar On Technology-Driven Biology For Future By Biocon Academy – Exclusively On Biotecnika

(1:5:56)

Success Story Of Dr. Kiran Mazumdar Shaw | Billionaire Entrepreneur | Founder \u0026 Chairperson -Biocon

(14:46)

Biocon Academy Corporate Film

(6:41)

Biocon, One Of India’s Top Pharma Stocks, Won’t Focus On India

(11:37)

Walk The Talk with Kiran Mazumdar Shaw

(12:5)

Biocon Sells 5.4% Stake In Syngene To Fund Viatris Biologics Biz Acquisition | Halftime Report

(2:54)

Biocon Biologics's Shreehas Tambe Speaks On US FDA's Observation | Bazaar Open Exchange | CNBC-TV18

(4:33)

Biocon's Mazumdar-Shaw Hopeful as India's Infections Slow

(4:35)

Pfizer not an outright out licensing deal: Biocon

(7:59)

Focusing On Specialty Pharma Currently: Biocon

(7:19)

Seeing promising results in drug repurposed for coronavirus treatment: Biocon

(3:54)

Biocon’s Billion Dollar Bet | Kiran Mazumdar Shaw of Biocon to ET NOW

(11:30)

Earnings Edge- Have Strong Orderbook For Q4: Biocon

(6:24)

Biocon Gets Its First Generic Formulation Approval In EU

(4:13)

Biocon in Focus

(2:42)

Your Stocks | What's the Future of Biocon? | Jubilant Food Hit new 52-week High | CNBC TV18

(12:33)